Skip to main navigation Skip to search Skip to main content

CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents

  • Tom Reuvekamp
  • , Lok Lam Ngai
  • , Daphne den Hartog
  • , Jannemieke Carbaat-Ham
  • , Mona M.H.E. Fayed
  • , Willemijn J. Scholten
  • , Tim R. Mocking
  • , Dana A. Chitu
  • , Thomas Pabst
  • , Saskia K. Klein
  • , Georg Stussi
  • , Laimonas Griskevicius
  • , Dimitri Breems
  • , Danielle van Lammeren-Venema
  • , Rinske Boersma
  • , Gert J. Ossenkoppele
  • , Arjan A. van de Loosdrecht
  • , Costa Bachas
  • , Gerwin Huls
  • , David C. de Leeuw
  • Jacqueline Cloos*
*Corresponding author for this work
  • Vrije Universiteit Amsterdam
  • Amsterdam UMC
  • University of Amsterdam
  • University of Bern
  • University Medical Centre Groningen
  • Meander Hospital Amersfoort
  • Ospedale Regionale (Bellinzona)
  • Vilnius University
  • Ziekenhuis Netwerk Antwerpen (ZNA)
  • Haga Ziekenhuis
  • Amphia Hospital

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

10 Citations (Scopus)
84 Downloads (Pure)
Original languageEnglish
Pages (from-to)972-975
Number of pages4
JournalLeukemia
Volume39
Issue number4
DOIs
Publication statusPublished - Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this